Cardiology

fibers) •intraventricular conduction delay Frequent AVNRT •especially if frequent episodes occur despite drug treatment Wolff–Parkinson–White syndrome •to characterize the accessory pathway and ablate it Unexplained syncope •after a negative tilt test, or in the presence of known heart disease Cardiac arrest •in the absence of myocardial infarction Table 9.Potential indications for electrophysiology. AV: atrioventricular; AVNRT: atrioventricular nodal re-entrant tachycardia. Class Typically Mechanism Action Uses potential duration 1a Quinidine, Block sodium channels ↑ Supraventricular procainamide, (short dissociation and ventricular disopyramide time) tachycardias Rarely used 1b Lidocaine Block sodium channels ↓ Ventricular (lignocaine) (medium dissociation tachycardias time) Used post-MI 1c Flecainide, Block sodium channels ↔ Ventricular propafenone (long dissociation time) tachycardia 2 b-blockers, Abrogate sympathetic ↔ Commonly used for (eg, atenolol) drive ventricular and supraventricular arrhythmias post-MI 3 Amiodarone, Inhibit potassium ↑ Commonly used for sotalol current ventricular and supraventricular arrhythmias 4 Diltiazem, Block L-type calcium Block at Ventricular rate control verapamil channels AV node Termination of SVT Table 10.The Vaughan-Williams classification of antiarrhythmic drugs. AV: atrioventricular; MI: myocardial infarction; SVT: supraventricular tachycardia; ↑: increase in duration; ↓: decrease in duration; ↔: no change in duration. 141 Chapter 8 Inward Na+channels 50 Inward Outward Ca2+channels K+channels Lidocaine (lignocaine) 0 P2 Flecainide Quinidine
